Tower Hematology Oncology Medical Groulp

Oncology

Fred P. Rosenfelt, MD practices Oncology. He went to Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Fred Rosenfelt is a published doctor. He published 21 publications, including: 'Interferon therapy in myelomatosis.' He accepts all Medicare patients.

Publications

---

• A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell Lymphoma.
• The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid Leukemia.
• Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's Lymphoma resulting in durable clinical responses.
• Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed Lymphoma.
• Laparoscopic-guided biopsy for diagnosis of hepatic candidiasis.
• Incidental detection of hematopoietic hyperplasia on routine knee MR imaging.
• Severe hemolytic Anemia due to glucose-6-phosphate dehydrogenase deficiency and Epstein-Barr virus infection.
• Who should treat Hodgkin''s Disease?
• Cytomegalovirus infection and hemolytic Anemia due to glucose-6-phosphate dehydrogenase deficiency.
• Combination chemotherapy for Hodgkin's Disease.
• Treatment of superior vena cava syndrome.
• True histiocytic Lymphoma: an immunohistochemical and ultrastructural study of two cases.
• Sarcoidosis progressing to Lymphoma.
• Non-Hodgkin's Lymphoma in Homosexual Men.
• A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.
• Allergic reaction following administration of AMSA.
• Central nervous system involvement in non-Hodgkin's lymphoma: an Analysis of 105 cases.
• Diffuse histiocytic lymphoma presenting with gastrointestinal Tract lesions. The Stanford experience.
• Interferon therapy in Myelomatosis.
• Methotrexate and the need for continued research.

Schools

---

• Yale University

• Stanford University Med Center

Procedures Preformed

---

• Plasmapheresis
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Bladder Cancer
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Top MD
• Super Doctor

Education

---

• Stanford University
• Yale University School of Medicine

Hospital

---

• Cedars-Sinai Medical Center

Drug Facts

---

NPI NUMBER		1306842802
NPPES Provider LastName		ROSENFELT
NPPES Provider FirstName		FRED
NPPES Provider ZIPCode		902111850
NPPES Provider State		CA
Specialty Description		Hematology/Oncology
Total Claim Count		568.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1306842802
Last Name Of The Provider	ROSENFELT
First Name Of The Provider	FRED
View All

Similar Doctors

---

	Dr. David M. Hoffman, MD This Doctor is OpenDoctor Recommended.
	Dr. Linnea I. Chap, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles L. Wiseman, MD This Doctor is OpenDoctor Recommended.
	Dr. Dorothy J. Park, MD This Doctor is OpenDoctor Recommended.
	Dr. Arash A. Gabayan, MD This Doctor is OpenDoctor Recommended.
	Dr. Mitchell E. Gross, MD This Doctor is OpenDoctor Recommended.
	Dr. Julie A. Dunhill, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven J. O'Day, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Noam Z. Drazin, MD This Doctor is OpenDoctor Recommended.
	Dr. David B. Agus, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Nader Javadi, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog